Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.350
+0.010 (0.75%)
Nov 28, 2025, 1:00 PM EST - Market closed
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $10.99 million as of November 28, 2025. Its market cap has increased by 63.35% in one year.
Market Cap
10.99M
Enterprise Value
11.64M
1-Year Change
63.35%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $10.99M, a decrease of -97.36%. That is a compound annual growth rate of -40.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 10.99M | -29.99% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | 84.01M | -81.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |